Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity.
BACKGROUND
In cultured renal epithelial cells, exposure to oxalate, a constituent of many kidney stones, elicits a cascade of responses that often leads to cell death. Oxalate toxicity is mediated via generation of reactive oxygen species (ROS) in a process that depends at least in part upon lipid signaling molecules that are generated through membrane events that culminate in phospholipase A2 (PLA2) activation. The present studies asked whether mitochondria, a major site of ROS production, were targets of oxalate toxicity, and if so, whether mitochondrial responses to oxalate were mediated by PLA2 activation.


METHODS
Effects of oxalate and various lipids on mitochondrial membrane potential (DeltaPsim) were measured in Madin-Darby canine kidney (MDCK) cell monolayers using 5,5',6,6'-tetrachloro 1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide (JC-1), a DeltaPsim-sensitive dye. Other studies assayed caspases, serine proteases activated during apoptosis, in response to oxalate or lipid signaling molecules. Additional studies asked whether oxalate or lipids produced by PLA2 activation promoted ROS formation in isolated renal mitochondria.


RESULTS
Oxalate exposure decreased MDCK cell DeltaPsim within 30 minutes, a response attenuated by arachidonyl trifluoromethyl ketone (AACOCF3), an inhibitor of cytosolic PLA2 (cPLA2). Exposure to arachidonic acid or to lysophosphatidylcholine (lyso-PC), lipid products of PLA2 activation, or to ceramide, another lipid signal generated in MDCK cells following oxalate exposure, also depolarized MDCK cell DeltaPsim and increased the number of caspase-positive cells. Isolated renal mitochondria responded to oxalate, arachidonic acid, lyso-PC, and ceramide by increasing their accumulation of ROS, lipid peroxides, and oxidized thiol proteins.


CONCLUSIONS
These studies suggest that lipid signaling molecules released after oxalate-induced PLA2 activation trigger marked, rapid changes in mitochondrial function that may mediate toxicity in renal epithelial cells.
Cao
Lu-Cheng
LC
Department of Physiology, University of Massachusetts, Medical School, Worcester, Massachusetts 01655-0127, USA.
Honeyman
Thomas W
TW
Cooney
Rachel
R
Kennington
Lori
L
Scheid
Cheryl R
CR
Jonassen
Julie A
JA
D000818:Animals; D016718:Arachidonic Acid / Q000494:pharmacology; D001095:Arachidonic Acids / Q000494:pharmacology; D020169:Caspases / Q000378:metabolism; D002460:Cell Line; D004285:Dogs; D004789:Enzyme Activation / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D007425:Intracellular Membranes / Q000187:drug effects; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology*; D015227:Lipid Peroxidation / Q000187:drug effects; D008244:Lysophosphatidylcholines / Q000494:pharmacology; D008564:Membrane Potentials / Q000187:drug effects; D008928:Mitochondria / Q000187:drug effects* / Q000378:metabolism; D010070:Oxalates / Q000506:poisoning*; D010741:Phospholipases A / Q000037:antagonists & inhibitors; D054467:Phospholipases A2; D017382:Reactive Oxygen Species / Q000378:metabolism; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000494:pharmacology
D001095:Arachidonic Acids; D004791:Enzyme Inhibitors; D008244:Lysophosphatidylcholines; C064769:N-acetylsphingosine; D010070:Oxalates; D017382:Reactive Oxygen Species; C081565:arachidonyltrifluoromethane; C006065:We 201; D016718:Arachidonic Acid; D010741:Phospholipases A; D054467:Phospholipases A2; D020169:Caspases; D013110:Sphingosine